Clinical trials
Withdrawn Urinary Bladder Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Southern California | 2 |
| VA Office of Research and Development | 2 |
| Bioniche Life Sciences Inc. | 1 |
| Brigham and Women's Hospital | 1 |
| Brown University | 1 |
| CG Oncology, Inc. | 1 |
| Case Comprehensive Cancer Center | 1 |
| Daniel George, MD | 1 |
| Eisai Inc. | 1 |
| Ferring Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 25 |
| Non-Muscle Invasive Bladder Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Colorectal Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Neoplasms | 2 |
| Skin Neoplasms | 2 |
| Adenoviridae Infections | 1 |
| Carcinoma in Situ | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.